GL1X · GenesisL1 explorer

MolNFT v1 · #52215 · protein

Crystal structure of botulinum neurotoxin serotype a binding domain in complex with GT1B

2VU9 · Botulinum neurotoxin a heavy chain: “Crystal structure of botulinum neurotoxin serotype a binding domain in complex with GT1B”. X-ray diffraction, 5 ligands (GAL, SIA, BGC), 5 pockets (best druggability 0.54). MolNFT v1 #52215 on…

PDB
2VU9
Type
protein
Length
425 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin a heavy chain
EC
3.4.24.69
UniProt
P10845
Ligands
GAL, SIA, BGC, NGA, MG
Pockets
5 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin a heavy chain (EC 3.4.24.69)protein4257% helix, 45% strandP10845

Ligands and binding sites

  • GAL · beta-D-galactopyranose · sugar · 2 copies · chains A
  • SIA · N-acetyl-alpha-neuraminic acid · sugar · 2 copies · chains A
  • BGC · beta-D-glucopyranose · sugar
  • NGA · 2-acetamido-2-deoxy-beta-D-galactopyranose · sugar · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12250.540.7731empty
2550.510.8619empty
3880.370.7622empty
4790.330.7516empty
5500.290.7512GAL

Compared structures

  • 2VU9 · Crystal structure of botulinum neurotoxin serotype a binding domain in complex with GT1B · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.